CDER Data Standards Program
Similar Posts
Fantasy Aphrodisiac Chocolate may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Fantasy Aphrodisiac Chocolate, a product promoted and sold for sexual enhancement on various websites, including gearisle.com, and possibly in some retail stores.Infusion Pump Software Correction: Fresenius Kabi Issues Correction for Ivenix Large Volume Pump Software
Fresenius Kabi is correcting Ivenix LVP software due to anomalies that could cause serious patient harm or deathReviews of Pediatric Studies Conducted under BPCA and Pediatric assessments conducted under PREA from 2012 – present
The following are the medical, statistical, and clinical pharmacology reviews of pediatric studies conducted in response to a Written Request issued under the BPCA and pediatric assessments conducted under PREA.FDA In Brief: FDA Issues Draft Guidance to Encourage Cannabis-Related Clinical Research
FDA has issued draft guidance describing the agency’s current thinking on several topics relevant to clinical research related to the development of drugs containing cannabis or cannabis-derived compounds.Notices of Updates
Webpage providing notices of updates to FDA’s STIC webpages for antibacterial and antifungal drugs.FDA-TRACK: Prescription Drug User Fee Act Meeting Goals Summary
FDA-TRACK: Prescription Drug User Fee Act Meeting Goals Summary
